{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:39:25Z","timestamp":1790689165103,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>Congenital dyserythropoietic anemias (CDAs) are rare hereditary blood disorders characterized by ineffective erythropoiesis, hemolysis, and erythroblast morphologic abnormalities in the bone marrow. The 3 main types of CDA, I to III, and variant types of CDA, IV-VIII, have been described. The causative genes have been identified as<jats:italic toggle=\"yes\">CDAN1<\/jats:italic>,<jats:italic toggle=\"yes\">C15ORF41<\/jats:italic>,<jats:italic toggle=\"yes\">SEC23B<\/jats:italic>,<jats:italic toggle=\"yes\">KIF23<\/jats:italic>,<jats:italic toggle=\"yes\">KLF1<\/jats:italic>, and<jats:italic toggle=\"yes\">GATA1<\/jats:italic>. CDA type II is the most frequent form. Typical symptoms are jaundice, hepatosplenomegaly, mild-to-severe normocytic anemia, and inadequate reticulocyte response. We report an 18-year-old boy who had chronic mild congenital anemia, jaundice, and splenomegaly mimicking nonautoimmune hemolytic anemia since 18 months of age. Compound heterozygous mutations in<jats:italic toggle=\"yes\">SEC23B<\/jats:italic>gene were detected by the use of a gene-targeted next-generation sequencing panel: the already reported missense mutation c.40C&gt;T (p.Arg14Trp), and a new frameshift deletion (c.489_489delG, p.Val164Trpfs*3), confirming the diagnosis of CDA type II. The study underlines the molecular heterogeneity of CDA II and the importance of a precise diagnosis in rare congenital diseases such as CDA II. In consequence, it can be difficult to diagnose because of limited resources, financial constraint, and rarity of disease in the developing country. Advanced laboratories and new molecular approaches may help in diagnosing rare anemias.<\/jats:p>","DOI":"10.1097\/mph.0000000000001207","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T11:55:46Z","timestamp":1527335746000},"page":"e421-e423","source":"Crossref","is-referenced-by-count":11,"title":["Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia"],"prefix":"10.1097","volume":"40","author":[{"given":"Sultan","family":"Aydin Koker","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology, Dr. Beh\u00e7et Uz Children\u2019s Hospital, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba H.","family":"Karapinar","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Dr. Beh\u00e7et Uz Children\u2019s Hospital, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Oymak","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Dr. Beh\u00e7et Uz Children\u2019s Hospital, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda Maggiore Policlinico Hospital of Milan, UOC Hematology, UOS Pathophysiology of Anemia, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fermo","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda Maggiore Policlinico Hospital of Milan, UOC Hematology, UOS Pathophysiology of Anemia, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Gozmen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Dr. Beh\u00e7et Uz Children\u2019s Hospital, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Vergin","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Dr. Beh\u00e7et Uz Children\u2019s Hospital, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2003-02-0613","article-title":"Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation","volume":"102","author":"Heimpel","year":"2003","journal-title":"Blood"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3324\/haematol.2012.072207","article-title":"Clinical aspects and pathogenesis of congenital dyserythropoietic anemias:from morphology to molecular approach","volume":"97","author":"Iolascon","year":"2012","journal-title":"Haematologica"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1182\/blood.V87.10.4433.bloodjournal87104433","article-title":"The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum","volume":"87","author":"Alloisio","year":"1996","journal-title":"Blood"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ng.405","article-title":"Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II","volume":"41","author":"Schwarz","year":"2009","journal-title":"Nat Genet"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/humu.21077","article-title":"Congenital dyserythropoietic anaemiatype II (CDAII) is caused by mutations in the SEC23B gene","volume":"30","author":"Bianchi","year":"2009","journal-title":"Hum Mutat"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.cellbio.20.010403.105307","article-title":"Bi-directional protein transport between the ER and Golgi","volume":"20","author":"Lee","year":"2004","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tcb.2008.04.006","article-title":"Coordination of COPII vesicle trafficking by Sec. 23","volume":"18","author":"Fromme","year":"2008","journal-title":"Trends Cell Biol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3324\/haematol.2013.085522","article-title":"Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis","volume":"98","author":"Satchwell","year":"2013","journal-title":"Haematologica"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajh.23800","article-title":"Retrospective cohort study of 205 cases with congenital dyserythropoietic anaemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores","volume":"89","author":"Russo","year":"2014","journal-title":"Am J Hematol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bcmd.2014.04.003","article-title":"A novel variant mutation for congenital dyserythropoietic anemia, type II","volume":"53","author":"Song","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjh.14271","article-title":"Analysis of a cohort of 101 CDAII patients:description of 24 new molecular variants and genotype-phenotype correlations","volume":"175","author":"Bianchi","year":"2016","journal-title":"Br J Haematol"},{"key":"R12-20230918","article-title":"Use of next generation sequencing panel to clarify undiagnosed cases of hereditary hemolytic anemias, Meeting of the American Society of Hematology, Atlanta (abstract)","author":"Fermo","year":"2017","journal-title":"Blood"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0609.2010.01440.x","article-title":"Frequency of congenital dyserythropoietic anemias in Europe","volume":"85","author":"Heimpel","year":"2010a","journal-title":"Eur J Haematol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/ijlh.12335","article-title":"International Council for Standardization in Haematology. ICSH guidelines for the laboratory diagnosis of non-immune hereditary red cell membrane disorders","volume":"37","author":"King","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcmd.2010.03.005","article-title":"CDAII presenting as hydrops foetalis: molecular characterization of two cases","volume":"45","author":"Fermo","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00277-017-3116-5","article-title":"Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations","volume":"12","author":"Kedar","year":"2017","journal-title":"Ann Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201810000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T01:39:39Z","timestamp":1720316379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201810000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001207","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}